Peptide Antidotes to SARS-CoV-2 (COVID-19)
A. Watson, L. M. R. Ferreira, P. Hwang…·R. Stroud
This paper designs and tests SARS-BLOCK peptides as antidotes to SARS-CoV-2 by inhibiting spike protein-ACE2 binding and enhancing neutralizing antibody responses.